BioCentury | Apr 27, 2015
Company News

4SC, Menarini deal

4SC granted Menarini exclusive rights to develop and commercialize resminostat to treat cancer in the Asia-Pacific region, excluding Japan. Menarini’s Menarini Asia-Pacific Holdings Pte. Ltd. subsidiary is solely responsible for the oral pan- histone deacetylase...
BioCentury | May 15, 2000
Financial News

GeneTrol raises $3.9 million

...venture financing. Investors included Fortune Consulting Group; CYPAC Investment Management; Global Ventures; First BioVenture Capital; Asia Pacific Holdings...
BioCentury | Sep 15, 1997
Company News

Genta board of directors update

...Bobby Sandage, EVP of R&D and CSO at Interneuron Pharmaceuticals Inc.; Andrew Stein, chairman of Asia Pacific Holdings...
Items per page:
1 - 3 of 3
BioCentury | Apr 27, 2015
Company News

4SC, Menarini deal

4SC granted Menarini exclusive rights to develop and commercialize resminostat to treat cancer in the Asia-Pacific region, excluding Japan. Menarini’s Menarini Asia-Pacific Holdings Pte. Ltd. subsidiary is solely responsible for the oral pan- histone deacetylase...
BioCentury | May 15, 2000
Financial News

GeneTrol raises $3.9 million

...venture financing. Investors included Fortune Consulting Group; CYPAC Investment Management; Global Ventures; First BioVenture Capital; Asia Pacific Holdings...
BioCentury | Sep 15, 1997
Company News

Genta board of directors update

...Bobby Sandage, EVP of R&D and CSO at Interneuron Pharmaceuticals Inc.; Andrew Stein, chairman of Asia Pacific Holdings...
Items per page:
1 - 3 of 3